[HTML][HTML] Effectiveness and safety of combined therapy versus monotherapy based on immune checkpoint inhibitors and/or targeted drugs as salvage treatment for …
L Wei, L Gao, Z Hu, C Liu - Translational Cancer Research, 2021 - ncbi.nlm.nih.gov
Background The standard salvage regimen for the patients with advanced urothelial
carcinoma (UC) is uncertain, although lots of novel agents are recommended, including …
carcinoma (UC) is uncertain, although lots of novel agents are recommended, including …
Effectiveness and safety of combined therapy versus monotherapy based on immune checkpoint inhibitors and/or targeted drugs as salvage treatment for advanced …
L Wei, L Gao, Z Hu, C Liu - Translational Cancer Research, 2021 - europepmc.org
Background The standard salvage regimen for the patients with advanced urothelial
carcinoma (UC) is uncertain, although lots of novel agents are recommended, including …
carcinoma (UC) is uncertain, although lots of novel agents are recommended, including …
[PDF][PDF] Effectiveness and safety of combined therapy versus monotherapy based on immune checkpoint inhibitors and/or targeted drugs as salvage treatment for …
L Wei, L Gao, Z Hu, C Liu - 2021 - cdn.amegroups.cn
Background: The standard salvage regimen for the patients with advanced urothelial
carcinoma (UC) is uncertain, although lots of novel agents are recommended, including …
carcinoma (UC) is uncertain, although lots of novel agents are recommended, including …
Effectiveness and safety of combined therapy versus monotherapy based on immune checkpoint inhibitors and/or targeted drugs as salvage treatment for advanced …
L Wei, L Gao, Z Hu, C Liu - Translational cancer research, 2021 - pubmed.ncbi.nlm.nih.gov
Background The standard salvage regimen for the patients with advanced urothelial
carcinoma (UC) is uncertain, although lots of novel agents are recommended, including …
carcinoma (UC) is uncertain, although lots of novel agents are recommended, including …
[HTML][HTML] Effectiveness and safety of combined therapy versus monotherapy based on immune checkpoint inhibitors and/or targeted drugs as salvage treatment for …
L Wei, L Gao, Z Hu, C Liu - Translational Cancer Research, 2021 - tcr.amegroups.org
Background: The standard salvage regimen for the patients with advanced urothelial
carcinoma (UC) is uncertain, although lots of novel agents are recommended, including …
carcinoma (UC) is uncertain, although lots of novel agents are recommended, including …
Effectiveness and safety of combined therapy versus monotherapy based on immune checkpoint inhibitors and/or targeted drugs as salvage treatment for advanced …
L Wei, L Gao, Z Hu, C Liu - Translational Cancer Research, 2021 - europepmc.org
Background The standard salvage regimen for the patients with advanced urothelial
carcinoma (UC) is uncertain, although lots of novel agents are recommended, including …
carcinoma (UC) is uncertain, although lots of novel agents are recommended, including …
Effectiveness and safety of combined therapy versus monotherapy based on immune checkpoint inhibitors and/or targeted drugs as salvage treatment for advanced …
L Wei, L Gao, Z Hu, C Liu - Translational Cancer Research, 2021 - tcr.amegroups.org
Effectiveness and safety of combined therapy versus monotherapy based on immune checkpoint
inhibitors and/or targeted drugs as salvage treatment for advanced urothelial carcinoma: a …
inhibitors and/or targeted drugs as salvage treatment for advanced urothelial carcinoma: a …